Day: July 1, 2024

EAST RUTHERFORD, NJ, July 01, 2024 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced that the Company’s common stock was added to the Russell 2000® and Russell 3000® Indexes after the market closed on June 28, 2024. “Our inclusion in the Russell 2000® and Russell 3000® Indexes represents another milestone achieved on our journey and a testament to the Company’s compelling and growing potential in the deli space, reflective of the shift in consumer preferences towards fresh prepared foods,” said Adam L. Michaels, Chairman and CEO of Mama’s Creations. “Together, we have made unparalleled progress in the last twelve months towards our shared vision to become a one-stop-shop deli solutions platform. To that end, I expect that the...

IRVING, Texas, July 01, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a business process automation leader, today announced that its Board of Directors (the “Board”) has authorized Exela to consider a spin-off of its wholly-owned subsidiary, Exela Technologies BPA, LLC, to Exela stockholders to maximize shareholder value. The potential spin-off, if completed, would likely be structured so that all Exela stockholders as of a record date in the third or fourth quarter of 2024, to be determined by the Board, would (i) receive their pro-rata share of a newly formed holding company owning Exela’s business process automation business (the “BPA Business”) and (ii) continue to own Exela, as currently constituted, including its greater than 70% ownership in Nasdaq-listed XBP Europe Holdings,...

ATLANTA, July 01, 2024 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) announces it has been added as a member of the Russell 3000 Index, effective after the US market opens today, July 1, as part of the 2024 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means Perma-Fix’s automatic inclusion in the Russell 2000 Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Mark Duff, President and CEO of Perma-Fix, commented, “We are honored to...

Company achieves critical Project AMAZE manufacturing milestone to meet future demand for long duration battery storage TURTLE CREEK, Pa., July 01, 2024 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced it successfully launched commercial production on its first state-of-the-art (SotA) manufacturing line after being installed and commissioned in Turtle Creek, Pennsylvania, propelling the Company’s ability to produce Eos Z3TM batteries at scale. Launching commercial production marks a significant milestone in the Company’s operational capabilities and ability to serve the growing long duration energy storage demand. The process of bringing the line into...

ATHENS, Greece, July 01, 2024 (GLOBE NEWSWIRE) — TEN, Ltd. (the “Company”), a leading diversified crude, product, and LNG tanker operator, would like to remind its shareholders and the investing public of the new ticker symbol that comes into effect today. As such, the Company’s common shares will immediately transition from “TNP” to “TEN” on the New York Stock Exchange (“NYSE”), where it will continue to be listed under the name “Tsakos Energy Navigation Limited.” Additionally, the ticker symbols for the Company’s Series E Cumulative Perpetual Preferred Shares (“Series E Preferred Shares”) and Series F Cumulative Perpetual Preferred Shares (“Series F Preferred Shares”) will also change. The Series E Preferred Shares will transition from “TNP-PRE” to “TEN-PRE” and the Series F Preferred Shares will transition from “TNP-PRF” to...

Results demonstrate efficacy on bacterial growth in participants injected with RECCE® 327 (R327) at the highest tested dose of 4,000mg No serious adverse events and clinically significant changes observed, reinforcing safety profile of R327 The study determined an optimal dosing regimen for R327 intravenously, showing rapid onset and sustained impact on Escherichia coli via an ATP mechanism in the urine of dosed participants Recce on track to initiate Phase II trial of R327 in patients with urinary tract infections in H2 2024SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced positive data from a Phase I/II trial for urinary tract infections (UTIs) and urosepsis, demonstrating that its lead candidate,...

The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily dosing OV888/GV101 capsule was shown to be biologically active in participants and elicited dose-dependent pharmacodynamic effects within the planned therapeutic dose range A Phase 2 study for the treatment of cerebral cavernous malformations is expected to initiate in the second half of 2024NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, and Graviton Bioscience Corporation, a privately...